"Revolutionary Therapy Grows New Livers from Lymph Nodes in Human Trial"

Biotech company LyGenesis is conducting a clinical trial to grow miniature livers inside the lymph nodes of 12 adults with end-stage liver disease, aiming to provide an alternative to liver transplants. By injecting healthy liver cells into abdominal lymph nodes, the company hopes to spur the growth of enough healthy liver tissue to alleviate the need for a transplant. Early experiments in mice and pigs have shown promising results, with the potential for the new mini organs to take over vital liver functions. If successful, this approach could offer a life-saving alternative for patients with failing livers.